Trust Company’s AstraZeneca AZN Stock Holding History

Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$807	Hold	5	–	–	﹤0.01%	641
2026 Q2	$948	Hold	5	–	–	﹤0.01%	614
2026 Q1	$986	Hold	5	–	–	﹤0.01%	578
2025 Q4	$919	Buy	+5	New	+$877	﹤0.01%	574
2017 Q4	–	Sell	-200	Closed	-$14K	–	373
2017 Q3	$14K	Hold	200	–	–	0.01%	227
2017 Q2	$14K	Sell	200 -75	-27%	-$4.9K	0.01%	237
2017 Q1	$17K	Hold	275	–	–	0.01%	250
2016 Q4	$15K	Hold	275	–	–	0.01%	258
2016 Q3	$18K	Hold	275	–	–	0.01%	248
2016 Q2	$17K	Hold	275	–	–	0.01%	244
2016 Q1	$15K	Sell	275 -30	-10%	-$1.8K	0.01%	248
2015 Q4	$20.7K	Sell	305 -135	-31%	-$8.85K	0.01%	229
2015 Q3	$28K	Buy	440 +240	+120%	+$15.8K	0.02%	211
2015 Q2	$13K	Hold	200	–	–	0.01%	273
2015 Q1	$14K	Buy	+200	New	+$13.9K	0.01%	225

Other funds holding AZN

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

PNC

Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return

CCM

Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CNBT

Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Trust Company's AZN Position: Q3 2026 in Review

Trust Company held its AstraZeneca (AZN) position steady in Q3 2026 at 5 shares worth $807. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Trust Company first reported a position in AZN in Q1 2015 and has held it in 15 quarters since. The position peaked at $28K in Q3 2015. 64 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Trust Company held 5 shares of AstraZeneca worth $807 as of Q3 2026.
Trust Company left its AstraZeneca share count unchanged in Q3 2026.
AstraZeneca made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #641 holding.
Trust Company first reported a position in AstraZeneca in Q1 2015 and has held it in 15 quarters since.
Trust Company's AstraZeneca position peaked at $28K in Q3 2015.
64 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.